Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00209105 · ClinicalTrials.gov registry record
Characterizing Psychological Consequences of Childhood Trauma
A clinical trial of Major Depressive Disorder, sponsored by Emory University.
- Completed
- Registry status
- 113
- Enrollment target
- 1
- Study location
NCT00209105 is a study of Major Depressive Disorder that has completed, run by Emory University. The registered enrollment target is 113 participants, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00209105, a study of Major Depressive Disorder, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 113 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will characterize the mental health consequences of early-life trauma.
Conditions Studied
Interventions
- DRUG DEX-CRF stimulation test
- BEHAVIORAL Psychosocial stress induction
- PROCEDURE Brain imaging of sad mood , self-reference, reward
- BEHAVIORAL Acoustic startle
Study Locations (1)
Georgia
- General Clinical Research Center at Emory University Hospital - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2005-01 |
| Est. Completion | 2011-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00209105
The ClinicalTrials.gov registry entry for NCT00209105 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (70% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Major Depressive Disorder appearing as the primary indexed condition, and to 4 interventions - of which DEX-CRF stimulation test is the first listed.
NCT00209105 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT00209105 about?
NCT00209105 is a clinical study titled "Characterizing Psychological Consequences of Childhood Trauma". This study will characterize the mental health consequences of early-life trauma.
What is the current status of trial NCT00209105?
This trial is currently completed. The enrollment target is 113 participants. The study started on 2005-01. Estimated completion is 2011-03.
What conditions does trial NCT00209105 study?
This clinical trial studies the following conditions: Major Depressive Disorder.
What interventions are being tested in trial NCT00209105?
The interventions under investigation include: DEX-CRF stimulation test (DRUG), Psychosocial stress induction (BEHAVIORAL), Brain imaging of sad mood , self-reference, reward (PROCEDURE), Acoustic startle (BEHAVIORAL).
Who is sponsoring clinical trial NCT00209105?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00209105 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Major Depressive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar Disorder
RECRUITING · Early Phase 1
-
Taking Action for College Students
RECRUITING · NA
-
Neural Response to Inflammatory Challenge in Major Depressive Disorder
RECRUITING · Phase 1
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Targeting Large-scale Networks in Depression With Real-time Functional Magnetic Resonance Imaging (fMRI) Neurofeedback
RECRUITING · NA
-
Neural Correlates of Stress and Perceived Control in Adolescent Depression
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.